| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |